Insider Trading & Ownership - Tammenoms Bakker Juliet

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Tammenoms Bakker Juliet
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-05-17
Purchase
2024-05-21
4:11 pm
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
5,000$61.09$305,45736,388
(Indirect
Direct)
View
2024-02-12
Purchase
2024-02-15
4:15 pm
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
8,000$50.83$406,67331,388
(Indirect
Direct)
View
2023-11-28
Sale
2023-11-30
7:32 pm
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
494,313$29.73$14,695,695471,098
(Indirect
Direct)
View
2023-11-14
Sale
2023-11-16
7:31 pm
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
500,000$27.18$13,590,750960,791
(Indirect
Direct)
View
2023-11-07
Purchase
2023-11-09
8:32 pm
Lexeo Therapeutics Inc.LXEOLongitude Capital Partners IV LLC
Longitude Venture Partners IV L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
454,545$11$4,999,9952,567,100
(Indirect)
View
2023-09-07
Sale
2023-09-11
6:15 pm
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
32,950$30.14$992,9691,460,791
(Indirect
Direct)
View
2023-08-25
Sale
2023-08-28
7:44 pm
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
16,208$29.25$474,1291,317,027
(Indirect
Direct)
View
2023-08-17
Sale
2023-08-18
4:08 pm
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
33,135$29.62$981,5701,775,863
(Indirect
Direct)
View
2023-02-10
Purchase
2023-02-13
6:20 pm
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
480,000$12.5$6,000,0002,997,321
(Indirect
Direct)
View
2023-02-06
Purchase
2023-02-08
7:40 pm
Vera Therapeutics Inc.VERALongitude Capital Partners IV LLC
Longitude Prime Partners LLC
Longitude Prime Fund L.P.
Longitude Venture Partners IV L.P.
Tammenoms Bakker Juliet
10% Owner
1,714,285$7$11,999,9955,144,212
(Indirect)
View
2022-04-19
Purchase
2022-04-21
6:04 pm
Inozyme Pharma Inc.INZYLongitude Capital Partners III LLC
Longitude Venture Partners III L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
1,355,000$3.69$4,999,9504,174,379
(Indirect)
View
2022-02-10
Purchase
2022-04-05
07:24 am
Vera Therapeutics Inc.VERALongitude Capital Partners IV LLC
Longitude Venture Partners IV L.P.
Tammenoms Bakker Juliet
10% Owner
333,333$15$4,999,9953,429,927
(Indirect)
View
2022-02-02
Purchase
2022-02-02
9:25 pm
Sierra Oncology Inc.SRRALongitude Capital Partners III LLC
Longitude Venture Partners III L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
Longitude Prime Partners LLC
Longitude Prime Fund L.P.
10% Owner
175,000$27$4,725,0002,139,771
(Indirect)
View
2021-08-03
Purchase
2021-08-05
7:41 pm
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
637,500$16$10,200,000562,838
(Indirect
Direct)
View
2021-07-19
Purchase
2021-07-20
9:39 pm
RAPID MICRO BIOSYSTEMS INC.RPIDLongitude Capital Partners II LLC
Longitude Venture Partners II L.P.
Longitude Prime Partners LLC
Longitude Prime Fund L.P.
ENRIGHT PATRICK G
Tammenoms Bakker Juliet
10% Owner
150,000$20$3,000,000779,032
(Indirect)
View
2021-05-18
Purchase
2021-05-18
8:20 pm
Vera Therapeutics Inc.VERALongitude Capital Partners IV LLC
Longitude Venture Partners IV L.P.
Tammenoms Bakker Juliet
10% Owner
909,090$11$9,999,9903,096,594
(Indirect)
View
2021-05-11
Purchase
2021-05-11
8:29 pm
Talaris Therapeutics Inc.TALSLongitude Capital Partners III LLC
Longitude Venture Partners III L.P.
ENRIGHT PATRICK G
Tammenoms Bakker Juliet
10% Owner
235,000$17$3,995,0003,220,775
(Indirect)
View
2020-10-20
Purchase
2020-10-22
7:53 pm
Eargo Inc.EARTammenoms Bakker Juliet
Director
10% Owner
233,333$18$4,199,9943,918,691
(Indirect)
View
2020-09-18
Sale
2020-09-22
6:01 pm
Axonics Modulation Technologies Inc.AXNXTammenoms Bakker Juliet
Director
9,167$42.67$391,1191,959,859
(Indirect
Direct)
View
2020-08-28
Sale
2020-09-01
7:33 pm
Molecular Templates Inc.MTEMLongitude Capital Partners III LLC
Longitude Venture Partners III L.P.
ENRIGHT PATRICK G
Tammenoms Bakker Juliet
10% Owner
3,496$10.75$37,5683,202,530
(Indirect)
View
2020-08-14
Sale
2020-08-18
5:32 pm
Axonics Modulation Technologies Inc.AXNXTammenoms Bakker Juliet
Director
2,393$43.22$103,4221,965,526
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-11-30
Other
2023-11-30
7:32 pm
N/A
N/A
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
447,710$0471,098
(Indirect)
View
2023-11-07
Conversion
2023-11-09
8:32 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOLongitude Capital Partners IV LLC
Longitude Venture Partners IV L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
24,018,702$02,567,100
(Indirect)
View

Ownership
2023-11-02
9:36 pm
N/A
N/A
Lexeo Therapeutics Inc.LXEOLongitude Capital Partners IV LLC
Longitude Venture Partners IV L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
0$02,067,743
(Indirect)
View
2023-08-24
Other
2023-08-28
7:44 pm
N/A
N/A
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
268,686$01,317,027
(Indirect)
View
2023-08-09
Other
2023-08-11
4:13 pm
N/A
N/A
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
530,100$02,339,098
(Indirect)
View
2023-06-14
Other
2023-06-16
4:49 pm
N/A
N/A
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
268,761$01,829,259
(Indirect)
View
2023-06-01
Option Award
2023-06-05
4:36 pm
N/A
N/A
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
5,731$02,539,037
(Direct)
View
2023-05-26
Other
2023-05-31
6:09 pm
N/A
N/A
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
530,285$03,063,591
(Indirect)
View
2022-06-02
Option Award
2022-06-03
8:24 pm
N/A
N/A
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
10,349$02,517,321
(Direct)
View
2022-04-27
Other
2022-04-29
7:07 pm
N/A
N/A
Sierra Oncology Inc.SRRALongitude Capital Partners III LLC
Longitude Venture Partners III L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
Longitude Prime Partners LLC
Longitude Prime Fund L.P.
10% Owner
2,155,801$02,163,816
(Indirect)
View
2022-01-25
Exercise
2022-01-27
9:23 pm
2020-01-22
2022-04-10
Sierra Oncology Inc.SRRALongitude Capital Partners III LLC
Longitude Venture Partners III L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
1,964,576$13.21,964,771
(Indirect)
View
2021-08-03
Conversion
2021-08-05
7:41 pm
N/A
N/A
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
3,727,226$0562,838
(Indirect)
View
2021-08-03
Exercise
2021-08-05
7:41 pm
2017-02-24
N/A
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
72,604$0562,838
(Indirect)
View
2021-08-03
Tax Withholding
2021-08-05
7:41 pm
N/A
N/A
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
28,125$0562,838
(Indirect)
View
2021-07-30
Option Award
2021-08-02
8:17 pm
N/A
N/A
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
5,859$05,859
(Direct)
View

Ownership
2021-07-29
10:42 am
N/A
N/A
RxSight Inc.RXSTTammenoms Bakker Juliet
Director
0$01,891,738
(Indirect)
View
2021-07-19
Conversion
2021-07-20
9:39 pm
N/A
N/A
RAPID MICRO BIOSYSTEMS INC.RPIDLongitude Capital Partners II LLC
Longitude Venture Partners II L.P.
Longitude Prime Partners LLC
Longitude Prime Fund L.P.
ENRIGHT PATRICK G
Tammenoms Bakker Juliet
10% Owner
23,838,431$0779,032
(Indirect)
View

Ownership
2021-07-14
7:35 pm
N/A
N/A
RAPID MICRO BIOSYSTEMS INC.RPIDLongitude Capital Partners II LLC
Longitude Venture Partners II L.P.
ENRIGHT PATRICK G
Tammenoms Bakker Juliet
10% Owner
0$06,558,675
(Indirect)
View
2021-05-17
Other
2021-05-19
4:58 pm
N/A
N/A
Eargo Inc.EARTammenoms Bakker Juliet
Director
10% Owner
1,005,012$01,015,036
(Indirect)
View
2021-05-18
Conversion
2021-05-18
8:20 pm
N/A
N/A
Vera Therapeutics Inc.VERALongitude Capital Partners IV LLC
Longitude Venture Partners IV L.P.
Tammenoms Bakker Juliet
10% Owner
2,187,504$03,096,594
(Indirect)
View

Ownership
2021-05-13
7:27 pm
N/A
N/A
Vera Therapeutics Inc.VERALongitude Capital Partners IV LLC
Longitude Venture Partners IV L.P.
Tammenoms Bakker Juliet
10% Owner
0$02,187,504
(Indirect)
View
2021-05-11
Conversion
2021-05-11
8:29 pm
N/A
N/A
Talaris Therapeutics Inc.TALSLongitude Capital Partners III LLC
Longitude Venture Partners III L.P.
ENRIGHT PATRICK G
Tammenoms Bakker Juliet
10% Owner
5,971,550$03,220,775
(Indirect)
View

Ownership
2021-05-06
9:25 pm
N/A
N/A
Talaris Therapeutics Inc.TALSLongitude Capital Partners III LLC
Longitude Venture Partners III L.P.
ENRIGHT PATRICK G
Tammenoms Bakker Juliet
10% Owner
0$02,985,775
(Indirect)
View
2021-04-14
Other
2021-04-15
9:04 pm
N/A
N/A
Eargo Inc.EARTammenoms Bakker Juliet
Director
10% Owner
1,005,012$01,010,024
(Indirect)
View
2020-11-16
Other
2020-11-18
7:11 pm
N/A
N/A
89bio Inc.ETNBLongitude Capital Partners III LLC
Longitude Venture Partners III L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
855,944$0856,835
(Indirect)
View
2020-10-20
Conversion
2020-10-22
7:53 pm
N/A
N/A
Eargo Inc.EARTammenoms Bakker Juliet
Director
10% Owner
3,685,358$03,918,691
(Indirect)
View
2020-10-15
Option Award
2020-10-19
6:07 pm
N/A
2030-10-14
Eargo Inc.EARTammenoms Bakker Juliet
Director
10% Owner
6,666$06,666
(Direct)
View

Ownership
2020-10-15
8:18 pm
N/A
N/A
Eargo Inc.EARTammenoms Bakker Juliet
Director
10% Owner
0$03,685,358
(Indirect)
View
2020-08-24
Option Award
2020-08-26
8:17 pm
N/A
N/A
Axonics Modulation Technologies Inc.AXNXTammenoms Bakker Juliet
Director
3,500$01,969,026
(Direct)
View
Goto 0, 1, Next